DE69903612T2 - Verwendung von fgf-5 polypetiden zur vorbeugung des absterbens retinaler neuronen und behandlung okularer krankheiten - Google Patents
Verwendung von fgf-5 polypetiden zur vorbeugung des absterbens retinaler neuronen und behandlung okularer krankheitenInfo
- Publication number
- DE69903612T2 DE69903612T2 DE69903612T DE69903612T DE69903612T2 DE 69903612 T2 DE69903612 T2 DE 69903612T2 DE 69903612 T DE69903612 T DE 69903612T DE 69903612 T DE69903612 T DE 69903612T DE 69903612 T2 DE69903612 T2 DE 69903612T2
- Authority
- DE
- Germany
- Prior art keywords
- retinal
- retinopathies
- fgf
- cells
- retinopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4138398A | 1998-03-12 | 1998-03-12 | |
US09/240,952 US6331523B1 (en) | 1998-03-12 | 1999-01-29 | Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 |
PCT/US1999/005375 WO1999045952A2 (en) | 1998-03-12 | 1999-03-10 | Method of preventing the death of retinal neurons and treating ocular diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69903612D1 DE69903612D1 (de) | 2002-11-28 |
DE69903612T2 true DE69903612T2 (de) | 2003-07-10 |
Family
ID=26718088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69903612T Expired - Lifetime DE69903612T2 (de) | 1998-03-12 | 1999-03-10 | Verwendung von fgf-5 polypetiden zur vorbeugung des absterbens retinaler neuronen und behandlung okularer krankheiten |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1061943B1 (de) |
JP (2) | JP3764047B2 (de) |
AT (1) | ATE226444T1 (de) |
AU (1) | AU754380B2 (de) |
CA (1) | CA2322380C (de) |
DE (1) | DE69903612T2 (de) |
ES (1) | ES2186340T3 (de) |
IL (1) | IL138033A0 (de) |
WO (1) | WO1999045952A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6943153B1 (en) | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
CA2367375A1 (en) * | 1999-03-15 | 2000-09-21 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
CA2384696A1 (en) * | 1999-10-02 | 2001-04-12 | The Government Of The United States Of America | Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
EP2311465A1 (de) * | 2003-04-18 | 2011-04-20 | Advanced Medicine Research Institute | Mittel zur Behandlung von Krankheiten zur Aufbringung auf das Auge |
JP2008064459A (ja) * | 2004-12-24 | 2008-03-21 | Univ Kurume | 色素上皮由来因子の定量法 |
GB0700133D0 (en) | 2007-01-04 | 2007-02-14 | Humabs Llc | Human cytomegalovirus neutralising antibodies and use thereof |
US7947274B2 (en) | 2007-01-04 | 2011-05-24 | Humabs, LLC. | Human cytomegalovirus neutralising antibodies and use thereof |
UA106354C2 (ru) | 2008-07-16 | 2014-08-26 | Инститьют Фо Рисерч Ин Байомедсин | Антитела, нейтрализующие цитомегаловирус человека, и их применение |
TWI698240B (zh) | 2012-05-15 | 2020-07-11 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd) |
WO2015129809A1 (ja) * | 2014-02-28 | 2015-09-03 | 国立大学法人京都大学 | 虚血性眼疾患の処置用の医薬組成物 |
US10000741B2 (en) | 2014-03-17 | 2018-06-19 | Adverum Biotechnologies, Inc. | Compositions and methods for enhanced gene expression in cone cells |
WO2016141078A1 (en) | 2015-03-02 | 2016-09-09 | Avalanche Biotechnologies, Inc. | Compositions and methods for intravitreal delivery of polynucleotides to retinal cones |
GB2545763A (en) | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA941729B (en) * | 1993-03-12 | 1994-10-13 | Max Planck Gesellschaft | Treatment of motor neuron diseases with fibroblast growth factor-5 (fgf-5). |
WO1995024928A2 (en) * | 1994-03-15 | 1995-09-21 | Prizm Pharmaceuticals, Inc. | Heparin-binding growth factors for gene therapy and anterior eye disorders |
US5629284A (en) * | 1995-07-24 | 1997-05-13 | Meiji Milk Products Co., Ltd. | Method for treating retinal diseases |
ES2258788T3 (es) * | 1996-10-16 | 2006-09-01 | Zymogenetics, Inc. | Homologos del factor de crecimiento de fibroblastos. |
-
1999
- 1999-03-10 DE DE69903612T patent/DE69903612T2/de not_active Expired - Lifetime
- 1999-03-10 CA CA002322380A patent/CA2322380C/en not_active Expired - Lifetime
- 1999-03-10 AU AU30813/99A patent/AU754380B2/en not_active Expired
- 1999-03-10 AT AT99912439T patent/ATE226444T1/de not_active IP Right Cessation
- 1999-03-10 JP JP2000535365A patent/JP3764047B2/ja not_active Expired - Lifetime
- 1999-03-10 ES ES99912439T patent/ES2186340T3/es not_active Expired - Lifetime
- 1999-03-10 EP EP99912439A patent/EP1061943B1/de not_active Expired - Lifetime
- 1999-03-10 WO PCT/US1999/005375 patent/WO1999045952A2/en active IP Right Grant
- 1999-03-10 IL IL13803399A patent/IL138033A0/xx active IP Right Grant
-
2005
- 2005-10-04 JP JP2005290896A patent/JP2006089489A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2322380A1 (en) | 1999-09-16 |
CA2322380C (en) | 2008-10-14 |
IL138033A0 (en) | 2001-10-31 |
WO1999045952A2 (en) | 1999-09-16 |
DE69903612D1 (de) | 2002-11-28 |
AU754380B2 (en) | 2002-11-14 |
AU3081399A (en) | 1999-09-27 |
EP1061943B1 (de) | 2002-10-23 |
JP3764047B2 (ja) | 2006-04-05 |
EP1061943A1 (de) | 2000-12-27 |
WO1999045952A3 (en) | 2000-11-23 |
ATE226444T1 (de) | 2002-11-15 |
ES2186340T3 (es) | 2003-05-01 |
JP2006089489A (ja) | 2006-04-06 |
JP2002526381A (ja) | 2002-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001009327A3 (en) | Method of preventing the injury or death of retinal cells and treating ocular diseases | |
DE69903612D1 (de) | Verwendung von fgf-5 polypetiden zur vorbeugung des absterbens retinaler neuronen und behandlung okularer krankheiten | |
NO982275D0 (no) | FremgangsmÕter for behandling av fotoreseptorer under anvendelse av proteinprodukt av gliacellelinjeavledet neurotrof faktor (GDNF) | |
Chang et al. | Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure | |
Tsutsumi-Miyahara et al. | The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation | |
Schwartz et al. | Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein | |
Roddy et al. | Stanniocalcin-1 rescued photoreceptor degeneration in two rat models of inherited retinal degeneration | |
BR9611748A (pt) | Uso de um produto protéico de fator neurotrófico derivado de linhagem de célula glial | |
NL970039I2 (nl) | Prostaglandinederivaten voor de behandeling van glaucoma of oculaire hypertensie. | |
Jirsova et al. | Cold jet: a method to obtain pure Schwann cell cultures without the need for cytotoxic, apoptosis-inducing drug treatment | |
Nishihara et al. | Surface scattering in implanted hydrophobic intraocular lenses | |
WO2000053760A3 (en) | Method of preventing the death of retinal neurons and treating ocular diseases | |
CA2287780C (en) | Use of nerve growth factor for the storage, culture or treatment of cornea | |
Tandon et al. | Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis | |
ITRM20100100A1 (it) | Composizione farmaceutica a base di glicirrizina e polimero eg56 per la preparazione di prodotti ad azione flogolitica. | |
Abe et al. | Lens epithelial changes and mutated gene expression in patients with myotonic dystrophy | |
DE69028877D1 (de) | Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden | |
WO2002089857A3 (en) | Trans-viral vector mediated gene transfer to the retina | |
EP0083261B1 (de) | Therapeutische Zusammensetzung für die Behandlung von Schwierigkeiten des Anpassungsvermögens des Auges | |
JPS6284025A (ja) | 繊維芽細胞増殖促進作用を有する胎盤由来蛋白加水分解物 | |
Travers et al. | A controlled trial of adenine arabinoside and trifluorothymidine in herpetic keratitis | |
RU2167667C1 (ru) | Гомеопатическое средство для рассасывания помутнений роговицы | |
Levisky et al. | Myotonic dystrophy, syringomyelia, and 2/13 translocation in the same family. | |
Rotman et al. | Two asymptomatic plaques on the chest of a young woman | |
Voaden | Techniques for neurochemical research on the retina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |